Blood-based biomarkers in patients with platinum-sensitive and resistant ovarian cancer treated with olaparib and cediranib: results from the UM9825 trial

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Nixon, A; Liu, J; Xiong, N; Hurwitz, HI; Lyu, J; Liu, Y; Starr, M; Brady, J; Swisher, E; Owzar, K; Wenham, R; Hendrickson, AW; Armstrong, D; Chan, N; Cohn, D; Lee, J-M; Penson, R; Cristea, M; Gaillard, S; Abbruzzese, J; Matsuo, K; Olawaiye, A; Kohn, E; Ivy, P; Secord, AA

Published Date

  • August 2021

Published In

Volume / Issue

  • 162 /

Start / End Page

  • S99 - S99

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

International Standard Serial Number (ISSN)

  • 0090-8258